2 hasil untuk "M. Awad"
Menampilkan 1–2 · 3,09 detik · RSS
-
Artikel Jurnal
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer
BACKGROUND: Neoadjuvant or adjuvant chemotherapy confers a modest benefit over surgery alone for resectable non-small-cell lung cancer (NSCLC). In early-phase trials, nivolumab-based neoadjuvant regimens have shown promising clinical activity; however, data from phase 3 trials are needed to confirm…
-
Artikel Jurnal Teks lengkap
Acquired Resistance to KRAS G12C Inhibition in Cancer
BACKGROUND: ). The mechanisms of acquired resistance to these therapies are currently unknown. METHODS: inhibitors. RESULTS: inhibitors. CONCLUSIONS: inhibitors, and new therapeutic strategies are required to delay and overcome this drug resistance in patients with cancer. (Funded by Mirati…